{"id":"NCT00494871","sponsor":"Bayer","briefTitle":"Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation","officialTitle":"Evaluation of the Efficacy and Safety of Rivaroxaban (BAY59-7939) for the Prevention of Stroke and Non-central Nervous System Systemic Embolism in Subjects With Non-valvular Atrial Fibrillation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2009-12","completion":"2010-01","firstPosted":"2007-07-02","resultsPosted":"2012-04-19","lastUpdate":"2015-04-20"},"enrollment":1280,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation"],"interventions":[{"type":"DRUG","name":"Rivaroxaban (Xarelto, BAY59-7939)","otherNames":[]},{"type":"DRUG","name":"Warfarin","otherNames":[]},{"type":"DRUG","name":"Rivaroxaban placebo","otherNames":[]},{"type":"DRUG","name":"Warfarin placebo","otherNames":[]}],"arms":[{"label":"Rivaroxaban (Xarelto, BAY59-7939)","type":"EXPERIMENTAL"},{"label":"Warfarin","type":"ACTIVE_COMPARATOR"}],"summary":"This is a clinical study evaluating the efficacy and safety of rivaroxaban for stroke prevention in patients with atrial fibrillation (originally described in Japanese).","primaryOutcome":{"measure":"Event Rate of the Composite Endpoint of Adjudicated Major Bleeding or Adjudicated Non-major Clinically Relevant Bleeding","timeFrame":"Up to 2 days after the last dose","effectByArm":[{"arm":"Rivaroxaban (Xarelto, BAY59-7939)","deltaMin":18.04,"sd":null},{"arm":"Warfarin","deltaMin":16.42,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.025"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":165,"countries":["Japan"]},"refs":{"pmids":["22664783","23052711","23352688","23229461","22813718","23337693","24477179","24189454","23954611","23903065","24705469"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":151,"n":639},"commonTop":["Nasopharyngitis","Epistaxis","Haemorrhage subcutaneous","Upper respiratory tract inflammation","Contusion"]}}